Contracting Out Frees Sponsors Up

According to Robert O'Brien, director operations-Packaging & Logistics at Almac Pharma Services, sponsor companies should consider if contracting activities to a CMO is more cost effective than performing those activities in-house. O'Brien points to direct access to specialists and equ...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical technology Europe 2024-07, Vol.36 (7), p.31-33
Main Author: Haigney, Susan
Format: Article
Language:English
Subjects:
Collaboration
Communication
Contractors
Corporate sponsorship
Cost control
Flexibility
Intellectual property
Manufacturing
Outsourcing
Packaging
Product testing
Quality control
Supply chains
Teams
Testing laboratories
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:According to Robert O'Brien, director operations-Packaging & Logistics at Almac Pharma Services, sponsor companies should consider if contracting activities to a CMO is more cost effective than performing those activities in-house. O'Brien points to direct access to specialists and equipment, a level of control of quality standards, and requirements for scale up as factors to consider when deciding whether to outsource or not. [...]intellectual property protection must be addressed to safeguard proprietary information during collaboration. [...]internal and partner teams should be cautious and thorough when migrating data, documentation, and intellectual property to avoid delays and errors during the transition.
ISSN:1753-7967